news releases

Vancouver, British Columbia, November 15, 2010 — Burcon NutraScience Corporation (TSX – BU) ("Burcon") announced today that, simultaneous to and in conjunction with executing the letter of intent to license CLARISOY® as announced today with Archer Daniels Midland Company (ADM), the two parties have also entered into an agreement amending the license and development agreement made among Burcon, Burcon NutraScience (MB) Corp. and ADM on September 16, 2003 and as amended June 1, 2007 (the "License and Development Agreement").

Vancouver, British Columbia, November 15, 2010 — Burcon NutraScience Corporation (TSX – BU) "Burcon") announced today that it has signed a non-binding letter of intent (the "Letter of Intent") with Archer Daniels Midland Company ("ADM") which details the intention of the two parties to enter into a license agreement pursuant to which Burcon will license (the "License") its CLARISOY® technology to ADM on an exclusive basis to produce, market and sell CLARISOY® soy protein isolates ("CLARISOY®" or the "Products") world-wide (the "Definitive Agreement").

September 10, 2010 — Burcon NutraScience Corporation (TSX – BU) ("Burcon" or the "Corporation") announced today that eight incumbent directors were re-elected to its Board at its annual meeting of shareholders held on September 9, 2010.

August 30, 2010 — Burcon NutraScience Corporation (TSX – BU) (“Burcon”) announced today that the U.S. Food and Drug Administration (FDA or the Agency) has issued a no objection letter with respect to Puratein® and Supertein™ canola protein isolates.

June 28, 2010 — Burcon today reported financial results for the fiscal year ended March 31, 2010 and provided a review of the year’s operations.

June 28, 2010 — Burcon is pleased to report on the latest business activities with respect to the commercialization of its CLARISOY® soy protein isolate.

April 26, 2010 — Burcon wishes to recognize Burcon director Dr. D. Lorne Tyrrell, who has been appointed as the inaugural director of the new Li Ka Shing Institute of Virology in Canada.

April 20, 2010 — Burcon or the “Corporation”) is pleased to announce the appointment of Mr. Alan Chan to its board of directors.

April 8, 2010 — Burcon announces today that the Division of Biotechnology and GRAS Notice Review of the Center for Food Safety and Applied Nutrition of the Food and Drug Administration (the “FDA”) has formally acknowledged receipt of Burcon’s GRAS notification.

February 4, 2010 — Burcon is pleased to announce today that it has received a notice of allowance from the United States Patent and Trademark Office for a patent application covering processes for the production of canola protein isolates whereby the resulting isolates are separated into their native underlying protein fractions.